Page last updated: 2024-10-29

isoniazid and Paget Disease, Extramammary

isoniazid has been researched along with Paget Disease, Extramammary in 1 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Paget Disease, Extramammary: A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1478)

Research Excerpts

ExcerptRelevanceReference
"Identifying the maximum safe dose (MAXSD) is an objective of both randomized clinical dose-finding studies for the safety endpoint and toxicological studies."1.31Identifying the maximum safe dose: a multiple testing approach. ( Hauschke, D; Hothorn, LA, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hothorn, LA1
Hauschke, D1

Other Studies

1 other study available for isoniazid and Paget Disease, Extramammary

ArticleYear
Identifying the maximum safe dose: a multiple testing approach.
    Journal of biopharmaceutical statistics, 2000, Volume: 10, Issue:1

    Topics: Animals; Antitubercular Agents; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Is

2000